501 related articles for article (PubMed ID: 29914865)
1. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
2. Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer.
Liang Q; Chiu J; Chen Y; Huang Y; Higashimori A; Fang J; Brim H; Ashktorab H; Ng SC; Ng SSM; Zheng S; Chan FKL; Sung JJY; Yu J
Clin Cancer Res; 2017 Apr; 23(8):2061-2070. PubMed ID: 27697996
[No Abstract] [Full Text] [Related]
3. Quantitation of faecal
Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
5. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
6. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
[TBL] [Abstract][Full Text] [Related]
7. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
8. Analysis of
Guven DC; Dizdar O; Alp A; Akdoğan Kittana FN; Karakoc D; Hamaloglu E; Lacin S; Karakas Y; Kilickap S; Hayran M; Yalcin S
Biomark Med; 2019 Jun; 13(9):725-735. PubMed ID: 31157977
[No Abstract] [Full Text] [Related]
9. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
[TBL] [Abstract][Full Text] [Related]
10. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
11. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
12. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
13. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
15. A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria.
Liang JQ; Zeng Y; Lau EYT; Sun Y; Huang Y; Zhou T; Xu Z; Yu J; Ng SC; Chan FKL
Cells; 2023 Apr; 12(9):. PubMed ID: 37174650
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fecal microbial markers in colorectal cancer detection.
Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
[TBL] [Abstract][Full Text] [Related]
18. A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn's Disease.
Guo S; Lu Y; Xu B; Wang W; Xu J; Zhang G
Front Microbiol; 2019; 10():1306. PubMed ID: 31244813
[No Abstract] [Full Text] [Related]
19. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
[TBL] [Abstract][Full Text] [Related]
20. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
